ARCHIVES

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

This article is from The Cancer Letter archive.

Vol. 04 No. 41 | October 13, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

June 18, 1993

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

NCI program announcement available, contract awards listed.

November 14, 2003